Chappe V - Search Results

1

Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury.

Lehmann C, Alizadeh-Tabrizi N, Hall S, Faridi S, Euodia I, Holbein B, Zhou J, Chappe V. Lehmann C, et al. Among authors: chappe v. Molecules. 2022 Jun 23;27(13):4036. doi: 10.3390/molecules27134036. Molecules. 2022. PMID: 35807282 Free PMC article.

2

Iron chelation as novel treatment for lung inflammation in cystic fibrosis.

Aali M, Caldwell A, House K, Zhou J, Chappe V, Lehmann C. Aali M, et al. Among authors: chappe v. Med Hypotheses. 2017 Jul;104:86-88. doi: 10.1016/j.mehy.2017.05.029. Epub 2017 May 27. Med Hypotheses. 2017. PMID: 28673599

3

Lung-Protective Ventilation Attenuates Mechanical Injury While Hypercapnia Attenuates Biological Injury in a Rat Model of Ventilator-Associated Lung Injury.

Ismaiel N, Whynot S, Geldenhuys L, Xu Z, Slutsky AS, Chappe V, Henzler D. Ismaiel N, et al. Among authors: chappe v. Front Physiol. 2022 Apr 21;13:814968. doi: 10.3389/fphys.2022.814968. eCollection 2022. Front Physiol. 2022. PMID: 35530505 Free PMC article.

4

Disrupted local innervation results in less VIP expression in CF mice tissues.

Semaniakou A, Brothers S, Gould G, Zahiremani M, Paton J, Chappe F, Li A, Anini Y, Croll RP, Chappe V. Semaniakou A, et al. Among authors: chappe v. J Cyst Fibros. 2021 Jan;20(1):154-164. doi: 10.1016/j.jcf.2020.06.013. Epub 2020 Jun 27. J Cyst Fibros. 2021. PMID: 32600901 Free article.

5

VIP reduction in the pancreas of F508del homozygous CF mice and early signs of Cystic Fibrosis Related Diabetes (CFRD).

Semaniakou A, Chappe F, Anini Y, Chappe V. Semaniakou A, et al. Among authors: chappe v. J Cyst Fibros. 2021 Sep;20(5):881-890. doi: 10.1016/j.jcf.2021.05.006. Epub 2021 May 24. J Cyst Fibros. 2021. PMID: 34034984 Free article.

6

Cystic fibrosis transmembrane conductance regulator dysfunction in VIP knockout mice.

Alcolado NG, Conrad DJ, Poroca D, Li M, Alshafie W, Chappe FG, Pelis RM, Anini Y, Xu Z, Hamidi S, Said SI, Chappe VM. Alcolado NG, et al. Am J Physiol Cell Physiol. 2014 Jul 15;307(2):C195-207. doi: 10.1152/ajpcell.00293.2013. Epub 2014 Jun 4. Am J Physiol Cell Physiol. 2014. PMID: 24898584 Free PMC article.

7

Modeling cystic fibrosis disease progression in patients with the rare CFTR mutation P67L.

MacKenzie IER, Paquette V, Gosse F, George S, Chappe F, Chappe V. MacKenzie IER, et al. Among authors: chappe v. J Cyst Fibros. 2017 May;16(3):335-341. doi: 10.1016/j.jcf.2017.03.008. Epub 2017 Apr 5. J Cyst Fibros. 2017. PMID: 28392015 Free article.

8

Animal Models in the Pathophysiology of Cystic Fibrosis.

Semaniakou A, Croll RP, Chappe V. Semaniakou A, et al. Among authors: chappe v. Front Pharmacol. 2019 Jan 4;9:1475. doi: 10.3389/fphar.2018.01475. eCollection 2018. Front Pharmacol. 2019. PMID: 30662403 Free PMC article. Review.

9

Vasoactive intestinal peptide increases cystic fibrosis transmembrane conductance regulator levels in the apical membrane of Calu-3 cells through a protein kinase C-dependent mechanism.

Chappe F, Loewen ME, Hanrahan JW, Chappe V. Chappe F, et al. Among authors: chappe v. J Pharmacol Exp Ther. 2008 Oct;327(1):226-38. doi: 10.1124/jpet.108.141143. Epub 2008 Jul 23. J Pharmacol Exp Ther. 2008. PMID: 18650246

10

Rescue of functional F508del cystic fibrosis transmembrane conductance regulator by vasoactive intestinal peptide in the human nasal epithelial cell line JME/CF15.

Rafferty S, Alcolado N, Norez C, Chappe F, Pelzer S, Becq F, Chappe V. Rafferty S, et al. Among authors: chappe f, chappe v. J Pharmacol Exp Ther. 2009 Oct;331(1):2-13. doi: 10.1124/jpet.109.155341. Epub 2009 Jul 7. J Pharmacol Exp Ther. 2009. PMID: 19584307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page